If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 39 Similar Profiles
Hematopoietic Stem Cells Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Myeloid Progenitor Cells Medicine & Life Sciences
Stem cells Chemical Compounds
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

1 Citation (Scopus)

A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma

on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), Jan 22 2019, In : International journal of hematology. 109, 1, p. 107-114 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Peripheral Blood Stem Cell Transplantation
Dexamethasone
Therapeutics
lenalidomide

Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)

Sunami, K., Matsumoto, M., Fuchida, S. I., Omoto, E., Takamatsu, H., Adachi, Y., Choi, I., Fujishima, N., Kiguchi, T., Miyamoto, T., Maeda, A., Suzumiya, J., Yamamura, R., Nagafuji, K., Nakazato, T., Kuroda, Y., Yujiri, T., Takamatsu, Y., Harada, M. & Akashi, K., Jan 1 2019, In : International Journal of Clinical Oncology.

Research output: Contribution to journalArticle

Cell Transplantation
Stem Cell Transplantation
Group Psychotherapy
Cell- and Tissue-Based Therapy
Multiple Myeloma
Phase II Clinical Trials
Clinical Trials, Phase I
Systemic Scleroderma
Hematopoietic Stem Cell Transplantation
Japan

Clinicopathological features of HCV-positive splenic diffuse large B cell lymphoma

Shimono, J., Miyoshi, H., Arakawa, F., Yamada, K., Sugio, T., Miyawaki, K., Eto, T., Miyagishima, T., Kato, K., Nagafuji, K., Akashi, K., Teshima, T. & Ohshima, K., May 1 2019, In : Annals of Hematology. 98, 5, p. 1197-1207 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Hepacivirus
B-Cell Lymphoma
RNA
Reverse Transcription
Hematology
Multiple Myeloma
Fees and Charges
Pharmaceutical Preparations
Organized Financing